NEW YORK (GenomeWeb) – Belgian cancer theranostics firm OncoDNA today announced an exclusive distribution deal granting Greek anatomic pathology laboratory Istomedica the exclusive rights to OncoDNA's products in Greece.

OncoDNA will be Istomedica's preferred supplier of clinical grade molecular theranostics using OncoDeep Dx, which links specific genes to targeted cancer treatments, and clinical cancer panels, in combination with Package Plus, a set of cancer tests based on immunohistochemical, fluorescent in situ hybridization, methylation, and other technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.